Experienced in Disseminated Intravascular Coagulation

Olga V. Pirogova

Saint Petersburg, SPE, RU 
Experienced in Disseminated Intravascular Coagulation
Saint Petersburg, SPE, RU 
OverviewLocationsClinical Research

Overview

Olga Pirogova practices in Saint Petersburg, Russian Federation. Ms. Pirogova is rated as an Experienced expert by MediFind in the treatment of Disseminated Intravascular Coagulation. Her top areas of expertise are Graft Versus Host Disease (GvHD), Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Leukemia, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 10 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Disseminated Intravascular Coagulation.

Gender
Female

Locations

Saint Petersburg, SPE, Russian Federation

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Dose-escalation Study of Graft-versus-host Disease Prophylaxis With High-dose Post-transplantation Bendamustine in Patients With Refractory Acute Leukemia
Dose-escalation Study of Graft-versus-host Disease Prophylaxis With High-dose Post-transplantation Bendamustine in Patients With Refractory Acute Leukemia
Enrollment Status: Completed
Publish Date: November 23, 2020
Intervention Type: Drug, Procedure
Study Phase: Phase 1/Phase 2

10 Total Publications

In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT.
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT.
Journal: Bone marrow transplantation
Published: September 04, 2023

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Pirogova's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile